Back
Range Nuclear Renaissance Index ETF Vs. Intra-Cellular Therapies Industry Stock Comparison
Sell
36
NUKZ
Range Nuclear Renaissance Index ETF
Last Price:
$45.26
Seasonality Move:
--
Buy
61
ITCI
Intra-Cellular Therapies
Last Price:
$126.17
Seasonality Move:
2.93%
Sell
36
Range Nuclear Renaissance Index ETF (NUKZ)
is a Sell
Is Range Nuclear Renaissance Index ETF a Buy, Sell or Hold?
-
The current Range Nuclear Renaissance Index ETF [NUKZ] share price is $45.39. The Score for NUKZ is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
NUKZ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Intra-Cellular Therapies (ITCI)
is a Buy
Is Intra-Cellular Therapies a Buy, Sell or Hold?
-
The current Intra-Cellular Therapies [ITCI] share price is $126.20. The Score for ITCI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
ITCI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NUKZ Stock Price Chart
What is Range Nuclear Renaissance Index ETF's stock price today?
-
The Range Nuclear Renaissance Index ETF share price today is $45.39Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKZ is experiencing buying pressure, which is a positive indicator for future bullish movement.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $126.20Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
NUKZ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.28 | Buy |
Relative Strength Index (14 RSI): | 59.92 | Buy |
Chaikin Money Flow: | 53197 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.63 - 44.11) | Buy |
Bollinger Bands (100): | (35.71 - 45.07) | Buy |
ITCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 10.51 | Buy |
Relative Strength Index (14 RSI): | 85.88 | Buy |
Chaikin Money Flow: | -5179263 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (76.16 - 110.04) | Buy |
Bollinger Bands (100): | (70.86 - 94.24) | Buy |
NUKZ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43.78 | Buy |
20-day SMA: | 42.86 | Buy |
50-day SMA: | 43.79 | Buy |
200-day SMA: | 36.52 | Buy |
8-day EMA: | 43.96 | Buy |
20-day EMA: | 43.48 | Buy |
50-day EMA: | 42.85 | Buy |
200-day EMA: | 23.2 | Buy |
ITCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 111.74 | Buy |
20-day SMA: | 95.26 | Buy |
50-day SMA: | 89.75 | Buy |
200-day SMA: | 77.18 | Buy |
8-day EMA: | 114.96 | Buy |
20-day EMA: | 101.39 | Buy |
50-day EMA: | 91.52 | Buy |
200-day EMA: | 79.08 | Buy |
Range Nuclear Renaissance Index ETF Earnings Growth & NUKZ Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $3.13 per share.
Range Nuclear Renaissance Index ETF Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Intra-Cellular Therapies Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |